Shares of Mid-cap health care company Azenta moved -17.7 this afternoon, and are now trading at $37.0 per share. On the other hand, the average analyst target price for the stock is $None.
Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally.
Azenta investors should be aware of the below:
Azenta has moved -35.6% over the last year.
The company has a price to earnings growth (PEG) ratio of 13.37. A number between 0 and 1 could mean that the market is undervaluing Azenta's estimated growth potential
Its Price to Book (P/B) ratio is 0.83
Azenta currently returns an annual dividend yield of None%.